A detailed history of Amundi transactions in Alvotech stock. As of the latest transaction made, Amundi holds 11,357 shares of ALVO stock, worth $140,031. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,357
Previous 6,700 69.51%
Holding current value
$140,031
Previous $81,000 66.67%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$10.76 - $12.99 $50,109 - $60,494
4,657 Added 69.51%
11,357 $135,000
Q1 2024

May 15, 2024

BUY
$11.36 - $17.27 $76,112 - $115,709
6,700 New
6,700 $81,000

Others Institutions Holding ALVO

About Alvotech


  • Ticker ALVO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 248,650,000
  • Market Cap $3.07B
  • Description
  • Alvotech, through its subsidiaries, develops and manufactures biosimilar medicines for patients worldwide. It offers biosimilar products in the therapeutic areas of autoimmune, eye, and bone disorders, as well as cancer. The company's lead program is AVT02, a high concentration formulation biosimilar to Humira to treat various inflammatory condi...
More about ALVO
Track This Portfolio

Track Amundi Portfolio

Follow Amundi and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amundi, based on Form 13F filings with the SEC.

News

Stay updated on Amundi with notifications on news.